Latest Biosynthesis Pharma Group News
Dec 27, 2017
Announces Binding Agreement to Acquire Biosynthesis Pharma Group December 17, 2017 â Vancouver, BC â Isodiol International Inc. (CSE: ISOL ) (OTC: ISOL F) (FSE: LB6A.F ) (the âCompanyâ or âIsodiolâ),a global Bioactive Phytoceutical innovator specializing in thedevelopment of pharmaceutical and wellness products, is pleased toannounce that the Company has entered into a binding agreement toacquire the Biosynthesis Pharma Group (BSPG), an industry leadingproducer of industrial hemp, itâs derivatives and pharmaceuticalcompounds for use in the medicinal, nutraceutical, food, and cosmeticindustries. Through BSPGâs industrial-sized, proprietary extractionmethodologies, BSPG produces high-purity, bioactive...... Some portions of the website are accessible only to members registered.